4//SEC Filing
Sablich Kim 4
Accession 0001765581-22-000057
CIK 0001232524other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:56 PM ET
Size
15.8 KB
Accession
0001765581-22-000057
Insider Transaction Report
Form 4
Sablich Kim
EVP & GM, North America
Transactions
- Tax Payment
Ordinary Shares
2022-06-06$149.25/sh−1,759$262,531→ 28,583 total - Sale
Ordinary Shares
2022-06-07$149.22/sh−250$37,306→ 26,745 total - Sale
Ordinary Shares
2022-06-07$151.87/sh−1,317$200,016→ 24,855 total - Sale
Ordinary Shares
2022-06-06$152.15/sh−1,388$211,184→ 27,195 total - Sale
Ordinary Shares
2022-06-07$148.21/sh−200$29,642→ 26,995 total - Sale
Ordinary Shares
2022-06-07$150.68/sh−573$86,337→ 26,172 total - Sale
Ordinary Shares
2022-06-07$152.59/sh−101$15,412→ 24,754 total
Footnotes (7)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.05 to $148.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.12 to $149.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F5]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.32 to $151.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F6]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $151.35 to $152.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.595 to $152.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001758790
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 4:56 PM ET
- Size
- 15.8 KB